NCT06483672 2024-07-03LungBrain001Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Not yet recruiting27 enrolled
NCT04978753 2021-07-27the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung CancerSun Yat-sen UniversityPhase 2 Unknown54 enrolled